Concepedia

Lori A. Ehrlich

LA

Statistics

Publications

8

Citations

786

H-Index

8

Active since

2003

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

University of Pittsburgh

UPMC Hillman Cancer Center

Dana-Farber Cancer Institute

Lori A. Ehrlich is an author at Center for Drug Evaluation and Research specializing in medicine, immunology, and clinical trials.

ORCID

Top concepts

Publications per year

2003–2023

8

Publications

8

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells

Junwon Lee, Ho Yeon Chung, Lori A. Ehrlich et al. · Blood · 2003 · 235 citations · Full text

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Lori A. Ehrlich, Ho Yeon Chung, Irene M. Ghobrial et al. · Blood · 2005 · 203 citations

MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells

Yasuo Oba, Junwon Lee, Lori A. Ehrlich et al. · Experimental Hematology · 2005 · 150 citations · Full text

, , +8

Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma

Lanie Francis, Yazan Alsayed, Xavier Leleu et al. · Clinical Cancer Research · 2006 · 91 citations · Full text

U.S. Food and Drug Administration approval summary: Eltrombopag for the treatment of pediatric patients with chronic immune (idiopathic) thrombocytopenia

Lori A. Ehrlich, Virginia E. Kwitkowski, Gregory H. Reaman et al. · Pediatric Blood & Cancer · 2017 · 36 citations

, , +20

Rows per page

1–5 of 8